Beximco Pharmaceuticals Limited Stock

Equities

BXPHARMA

BD0453BXPH04

Pharmaceuticals

End-of-day quote Dhaka S.E. 06:00:00 2024-05-15 pm EDT 5-day change 1st Jan Change
118.9 BDT +0.68% Intraday chart for Beximco Pharmaceuticals Limited -2.46% -18.67%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 44.51B 379M Sales 2025 * 50.42B 429M Capitalization 53.04B 452M
Net income 2024 * 5.25B 44.71M Net income 2025 * 6.24B 53.16M EV / Sales 2024 * 1.33 x
Net Debt 2024 * 5.96B 50.71M Net Debt 2025 * 878M 7.48M EV / Sales 2025 * 1.07 x
P/E ratio 2024 *
9.67 x
P/E ratio 2025 *
7.88 x
Employees 5,700
Yield 2024 *
3.49%
Yield 2025 *
4.42%
Free-Float 76.68%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.68%
1 week-2.46%
Current month-0.08%
1 month+1.02%
3 months-13.46%
6 months-18.67%
Current year-18.67%
More quotes
1 week
116.70
Extreme 116.7
126.20
1 month
113.20
Extreme 113.2
130.40
Current year
110.00
Extreme 110
146.20
1 year
110.00
Extreme 110
146.20
3 years
110.00
Extreme 110
255.40
5 years
47.36
Extreme 47.3636
255.40
10 years
30.84
Extreme 30.839
255.40
More quotes
Managers TitleAgeSince
Director of Finance/CFO 61 89-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Founder - 75-12-31
Founder - 75-12-31
Chief Executive Officer - 84-12-31
More insiders
Date Price Change Volume
24-05-16 118.9 +0.68% 55,821
24-05-15 118.1 -1.01% 40,792
24-05-14 119.3 -2.53% 108,459
24-05-13 122.4 -1.37% 70,876
24-05-12 124.1 +1.80% 74,181

End-of-day quote Dhaka S.E., May 15, 2024

More quotes
Beximco Pharmaceuticals Limited is a Bangladesh-based company which is a manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The Company is engaged in manufacturing and marketing of generic pharmaceutical formulation products covering a range of therapeutic categories. It offers products in different dosage forms, including Solid, Liquid, Cream and Ointment, Suppositories, Metered Dose Inhaler, Dry Powder Inhaler, Nasal Spray, Sterile, Lyophilized Injectable and Large Volume Intravenous Fluids. Besides formulation products, the Company also manufactures APIs and renders contract manufacturing services to other companies. Products of the Company are sold in domestic and international markets. The subsidiaries of the Company include Nuvista Pharma Limited (NPL), Synovia Pharma PLC (SPP), Beximco Pharma API Limited (BPAL).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
118.9 BDT
Average target price
168.3 BDT
Spread / Average Target
+41.58%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BXPHARMA Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW